Armata Pharmaceuticals (ARMP) Share-based Compensation Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 10.78% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 2.55% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 20.65% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 7.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.85% |
| Dec 31, 2025 | -8.20% |
| Sep 30, 2025 | -9.74% |
| Jun 30, 2025 | -15.38% |
| Mar 31, 2025 | 16.57% |
| Dec 31, 2024 | -18.91% |
| Sep 30, 2024 | 12.62% |
| Jun 30, 2024 | 13.75% |
| Mar 31, 2024 | -14.08% |
| Dec 31, 2023 | -39.28% |
| Sep 30, 2023 | -36.84% |
| Jun 30, 2023 | -33.96% |
| Mar 31, 2023 | -6.37% |
| Dec 31, 2022 | -7.91% |
| Sep 30, 2022 | -30.30% |
| Jun 30, 2022 | 9.44% |
| Mar 31, 2022 | 70.77% |
| Dec 31, 2021 | 773.29% |
| Sep 30, 2021 | 288.47% |
| Jun 30, 2021 | 311.68% |
| Mar 31, 2021 | 90.39% |
| Dec 31, 2020 | 86.92% |
| Sep 30, 2020 | 89.13% |
| Jun 30, 2020 | 44.71% |
| Mar 31, 2020 | 82.77% |
| Dec 31, 2019 | 52.15% |
| Sep 30, 2019 | 95.56% |
| Jun 30, 2019 | 9.73% |
| Mar 31, 2019 | -50.50% |
| Dec 31, 2018 | -26.08% |
| Sep 30, 2018 | -62.27% |
| Jun 30, 2018 | -37.00% |
| Mar 31, 2018 | 32.88% |
| Dec 31, 2017 | 29.34% |
| Sep 30, 2017 | -58.87% |
| Jun 30, 2017 | 8.36% |
| Mar 31, 2017 | -9.93% |
| Dec 31, 2016 | -53.74% |
| Sep 30, 2016 | 32.92% |
| Jun 30, 2016 | -16.99% |